Lotus Pharmaceuticals, Inc. Current with OTC MARKETS
- Wall Street ends lower as investors await earnings, inflation data
- Microsoft (MSFT) announces $19.7 billion acquisition of Nuance (NUAN)
- Dollar drops as traders prepare for inflation data
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
NORTH PORT, Fla., March 16, 2021 /PRNewswire/ -- Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has become current with OTC MARKETS. The company has fulfilled all Legal and Financial Requirements needed to achieve a Current, Green-Light Status.
Rivers stated, "We have big plans for the coming year. I couldn't be more excited. Being current means our future and current shareholders have the information they need to make the most accurate investment decisions."
Safe Harbor Statement
This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: The Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Lotus Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer
- Sense Rises Fast in Guidehouse Leaderboard for Home Energy Management
- Canadian Pacific, Kansas City Southern Assert Right to Have Transaction Reviewed Under Waiver Granted to KCS in 2001